My Profile
James Pethokoukis
Where politics and the economy intersect.
See all posts
Tue 1 Dec 2009 | 3:42 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Oxigene Inc
Oxigene Inc (OXGN.O) (Consolidated Issue listed on NASDAQ Global Market)
sector:
Healthcare
.
industry:
Biotechnology
ยท
View
OXGN
on other exchanges
As of 30 Nov 2009
1.16
USD
Price Change
-0.02
Percent Change
-1.69%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Langecker, Peter
58
2009
Interim Chief Executive Officer, Chief Development Officer
Laffer, Arthur
68
1998
Director
Fickling, Roy
43
2007
Director
Schwieterman, William
51
2007
Director
Kessel, Mark
67
2008
Director
Wood, Alastair
62
2008
Director
Chaplin, David
53
2008
Chief Scientific Officer, Head - Research and Development
Murphy, James
52
2004
Chief Financial Officer, Vice President
Shiebler, William
67
2009
Chairman of the Board
Find out more about OXGN.O
Insider Trading